Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Invasive Microwave Ablation in Early Stage breaST cancER, a Feasibility Study

NCT05887154 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05887154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05887154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Invasive Microwave Ablation in Early Stage breaST cancER, a Feasibility Study
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2023
Completion date
June 1, 2024
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage i